Sign up for our Oncology Central weekly news round-up

The patient perspective on… tumor mutation burden

Written by T.J. Sharpe

“You have cancer” – a tough phrase for anyone to hear.  “Your cancer is highly mutated” – a good phrase to hear for anyone with cancer?  Despite its ominous sound, that is precisely what new research is showing, giving hope to some cancer patients that immunotherapy treatments may work better for them.  Oncology Central is running a Spotlight on tumor mutation burden as a pathway for immuno-oncology to take the leap forward into the next phase of precision medicine. First, step back and understand what highly mutated cancers are.  A genetic mutation from a normal cell to an abnormal one...

To view this content, please register now for access

It's completely free